211 related articles for article (PubMed ID: 37496051)
1. A traditional gynecological medicine inhibits ovarian cancer progression and eliminates cancer stem cells via the LRPPRC-OXPHOS axis.
Jiang R; Chen Z; Ni M; Li X; Ying H; Fen J; Wan D; Peng C; Zhou W; Gu L
J Transl Med; 2023 Jul; 21(1):504. PubMed ID: 37496051
[TBL] [Abstract][Full Text] [Related]
2. Platinum-induced mitochondrial OXPHOS contributes to cancer stem cell enrichment in ovarian cancer.
Sriramkumar S; Sood R; Huntington TD; Ghobashi AH; Vuong TT; Metcalfe TX; Wang W; Nephew KP; O'Hagan HM
J Transl Med; 2022 May; 20(1):246. PubMed ID: 35641987
[TBL] [Abstract][Full Text] [Related]
3. Gossypol acetic acid regulates leukemia stem cells by degrading LRPPRC
Ai CJ; Chen LJ; Guo LX; Wang YP; Zhao ZY
World J Stem Cells; 2024 Apr; 16(4):444-458. PubMed ID: 38690512
[TBL] [Abstract][Full Text] [Related]
4. Targeting PUF60 prevents tumor progression by retarding mRNA decay of oxidative phosphorylation in ovarian cancer.
Zhang C; Ni X; Tao C; Zhou Z; Wang F; Gu F; Cui X; Jiang S; Li Q; Lu H; Li D; Wu Z; Zhang R
Cell Oncol (Dordr); 2024 Feb; 47(1):157-174. PubMed ID: 37632669
[TBL] [Abstract][Full Text] [Related]
5. Targeting the miR-34a/LRPPRC/MDR1 axis collapse the chemoresistance in P53 inactive colorectal cancer.
Yang Y; Yuan H; Zhao L; Guo S; Hu S; Tian M; Nie Y; Yu J; Zhou C; Niu J; Wang G; Song Y
Cell Death Differ; 2022 Nov; 29(11):2177-2189. PubMed ID: 35484333
[TBL] [Abstract][Full Text] [Related]
6. LRPPRC regulates malignant behaviors, protects mitochondrial homeostasis, mitochondrial function in osteosarcoma and derived cancer stem-like cells.
Zhao Z; Sun Y; Tang J; Yang Y; Xu X
BMC Cancer; 2023 Oct; 23(1):935. PubMed ID: 37789316
[TBL] [Abstract][Full Text] [Related]
7. The RNA-binding protein LRPPRC promotes resistance to CDK4/6 inhibition in lung cancer.
Zhou W; Wang W; Liang Y; Jiang R; Qiu F; Shao X; Liu Y; Fang L; Ni M; Yu C; Zhao Y; Huang W; Li J; Donovan MJ; Wang L; Ni J; Wang D; Fu T; Feng J; Wang X; Tan W; Fang X
Nat Commun; 2023 Jul; 14(1):4212. PubMed ID: 37452037
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2.
Zhuang RJ; Bai XX; Liu W
Cancer Biol Ther; 2019; 20(6):897-911. PubMed ID: 30862230
[TBL] [Abstract][Full Text] [Related]
9. Loss of hepatic LRPPRC alters mitochondrial bioenergetics, regulation of permeability transition and trans-membrane ROS diffusion.
Cuillerier A; Honarmand S; Cadete VJJ; Ruiz M; Forest A; Deschênes S; Beauchamp C; ; Charron G; Rioux JD; Des Rosiers C; Shoubridge EA; Burelle Y
Hum Mol Genet; 2017 Aug; 26(16):3186-3201. PubMed ID: 28575497
[TBL] [Abstract][Full Text] [Related]
10. Proteasome-Independent Protein Knockdown by Small-Molecule Inhibitor for the Undruggable Lung Adenocarcinoma.
Zhou W; Sun G; Zhang Z; Zhao L; Xu L; Yuan H; Li S; Dong Z; Song Y; Fang X
J Am Chem Soc; 2019 Nov; 141(46):18492-18499. PubMed ID: 31657561
[TBL] [Abstract][Full Text] [Related]
11. Role of leucine-rich pentatricopeptide repeat motif-containing protein (LRPPRC) for anti-apoptosis and tumourigenesis in cancers.
Tian T; Ikeda J; Wang Y; Mamat S; Luo W; Aozasa K; Morii E
Eur J Cancer; 2012 Oct; 48(15):2462-73. PubMed ID: 22326293
[TBL] [Abstract][Full Text] [Related]
12. MS4A15 acts as an oncogene in ovarian cancer through reprogramming energy metabolism.
Fang Y; Yu H; Zhou H
Biochem Biophys Res Commun; 2022 Apr; 598():47-54. PubMed ID: 35151203
[TBL] [Abstract][Full Text] [Related]
13. LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m
Yu Y; Deng H; Wang W; Xiao S; Zheng R; Lv L; Wang H; Chen J; Zhang B
Clin Transl Med; 2024 Feb; 14(2):e1583. PubMed ID: 38372449
[TBL] [Abstract][Full Text] [Related]
14. F-Box and Leucine-Rich Repeat Protein 20 (FBXL20), Negatively Regulated by microRNA (miR)-195-5p, Accelerates the Malignant Progression of Ovarian Cancer.
Wu D; Liu C; Hong L
Mol Biotechnol; 2021 Dec; 63(12):1235-1243. PubMed ID: 34338995
[TBL] [Abstract][Full Text] [Related]
15. Increased Hepatic Fatty Acids Uptake and Oxidation by LRPPRC-Driven Oxidative Phosphorylation Reduces Blood Lipid Levels.
Lei S; Sun RZ; Wang D; Gong MZ; Su XP; Yi F; Peng ZW
Front Physiol; 2016; 7():270. PubMed ID: 27462273
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of LRPPRC induces apoptosis in prostate cancer cells through the mitochondria-mediated pathway.
Zhou J; Zhang F; Hou X; Zhang N
Cancer Biother Radiopharm; 2014 Nov; 29(9):345-50. PubMed ID: 25379610
[TBL] [Abstract][Full Text] [Related]
17. Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro.
Liu Y; Ren CC; Yang L; Xu YM; Chen YN
J Cell Physiol; 2019 Apr; 234(4):3897-3909. PubMed ID: 30191987
[TBL] [Abstract][Full Text] [Related]
18. Integrated transcriptomic and proteomic analysis reveals Guizhi-Fuling Wan inhibiting STAT3-EMT in ovarian cancer progression.
Ma Q; Chen F; Liu Y; Wu K; Bu Z; Qiu C; Neamati N; Lu T
Biomed Pharmacother; 2024 Jan; 170():116016. PubMed ID: 38128180
[TBL] [Abstract][Full Text] [Related]
19. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
20. PGC1α/β Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer.
Ghilardi C; Moreira-Barbosa C; Brunelli L; Ostano P; Panini N; Lupi M; Anastasia A; Fiordaliso F; Salio M; Formenti L; Russo M; Arrigoni E; Chiaradonna F; Chiorino G; Draetta G; Marszalek JR; Vellano CP; Pastorelli R; Bani M; Decio A; Giavazzi R
Cancer Res; 2022 Apr; 82(7):1423-1434. PubMed ID: 35131872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
